Henry

Henry v. Angelini Pharms, Inc.

Bad Law
United States District Court, Eastern District of CaliforniaMarch 31, 20202:17-cv-02593California4,178 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF CALIFORNIA 10 TOBY HENRY, No. 2:17-cv-02593-TLN-KJN Plaintiff, v. ORDER ANGELINI PHARMA, INC.; TEVA PHARMACEUTICALS USA, INC.; and ENDO VENTURES LIMITED, Defendants. 17 This matter is before the Court on Defendants Angelini Pharma, Inc. (“Angelini Pharma”) and Endo Ventures Limited’s (“Endo Ventures”) (collectively, “Defendants”) Motions to Dismiss. (ECF Nos. 55, 56.) Plaintiff Toby Henry (“Plaintiff”) filed oppositions. (ECF Nos. 62, 63.) Defendants filed replies. (ECF Nos. 67, 68.) Also before the Court is Plaintiff’s Motion to Strike Angelini Pharma’s reply. (ECF No. 69.) For the reasons set forth below, the Court GRANTS Defendants’ Motions to Dismiss and DENIES Plaintiff’s Motion to Strike. /// /// /// /// /// I. FACTUAL AND PROCEDURAL BACKGROUND Plaintiff, a California resident, consumed a generic intermediate release formulation of trazodone hydrochloride1 after his physician prescribed…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.